ClinicalTrials.Veeva

Menu

The Use of Thromboelastometry (ROTEM) to Evaluate the Changes in Coagulation With Two Different Doses of Oxytocin Following Cesarean Delivery

Duke University logo

Duke University

Status

Withdrawn

Conditions

Coagulation Changes With Oxytocin

Treatments

Drug: Oxytocin

Study type

Interventional

Funder types

Other

Identifiers

NCT02063568
Pro00051122

Details and patient eligibility

About

The purpose of this study is to evaluate the differences in blood clotting seen in healthy patients given two different doses of oxytocin following cesarean delivery. The secondary objectives are to evaluate changes in blood pressure, rates of nausea and vomiting, and differences in blood loss with the two separate doses of oxytocin.

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • English speaking
  • Age > or = 18 yrs
  • Non-laboring women
  • cesarean delivery under spinal anesthesia with pfannenstiel incision
  • ASA I-III

Exclusion criteria

  • Height <5'0"
  • Allergy to phenylephrine
  • Severe cardiac disease in pregnancy with marked functional limitations
  • Women receiving NSAIDS, aspirin or other anticoagulants
  • Subject enrollment in another study involving a study medication within 30 days of cesarean delivery
  • Other physical or psychiatric condition which may impair the ability to cooperate with study data collection

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

0 participants in 2 patient groups

Low dose oxytocin infusion
Active Comparator group
Description:
oxytocin will be administered as an intravenous infusion at a rate of 0.33 units/min starting after fetal delivery upon umbilical cord clamping and continuing for a total of 30 minutes
Treatment:
Drug: Oxytocin
High dose oxytocin infusion
Active Comparator group
Description:
oxytocin will be administered as an intravenous infusion at a rate of 1.33 units/min starting after fetal delivery upon umbilical cord clamping and continuing for a total of 30 minutes
Treatment:
Drug: Oxytocin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems